[an error occurred while processing this directive]
[an error occurred while processing this directive]
[an error occurred while processing this directive]
If MELARIS® test results for a patient show an increased
risk for melanoma and pancreatic cancer, the following medical
management options may help reduce that risk. Preventive measures
may be taken following positive test results to help reduce the
risk and possibly prevent cancer.
Increased Surveillance for
Melanoma
Early detection through self-examination and
professional evaluation.
Regular full-body skin self-examinations by patient using
a hand-held mirror.
Clinical full-body skin exams every 6-12 months,
beginning in childhood.
Baseline photography of entire body.
Preventive Surgery for Melanoma
Biopsy and/or removal of suspicious
moles.
Preventive Lifestyle Adjustments for
Melanoma
Patient should limit exposure to the sun or ultraviolet radiation (e.g. tanning beds).
When going outside the patient should wear protective clothing, such as wide-brimmed hats, sunglasses, and long-sleeved shirts.
Patient should apply sunscreen with a Sun Protection Factor (SPF) of 15 or higher at regular intervals to prevent sunburns, especially in young children.
MELARIS® genetic testing can be provided by your practice or that of
a professional genetic risk counselor to help you in the medical management
of these high-risk patients. Knowing your patient's genetic status may impact
your threshold to biopsy suspicious mole or increase your patient's compliance
with skin examinations and sun avoidance behaviors.
